AstraZeneca’s trial breast cancer drug fails to meet primary goals
AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.
Drugs
Health
Pharma
Drugs
Health
Pharma
Takeda’s trials for epilepsy treatment fail to meet primary seizure goals
Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.
Drugs
Health
Pharma
Merck’s vaccine for pneumococcal disease gets FDA’s green light
The US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria.
Health
Medical
Pharma
US Surgeon General calls for warning labels on social media platforms
The US requires a warning label on social media platforms as they are significantly associated with “mental health harms” for adolescents, the United.
Drugs
Health
Pharma
FDA gives nod for AstraZeneca’s Imfinzi to treat endometrial cancer
The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.
Climate
Health
Pharma
Gray whales shrink in size by 13%, their numbers may fall: Oregon researchers
The size of gray whales found along the Oregon coast in the US has shrunk by 13% in the past 20-30 years —.
Drugs
Health
Pharma
US audit finds gaps in FDA’s procedures during infant formula crisis
The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took.
Drugs
Health
Pharma
AstraZeneca’s trial drug for mantle cell lymphoma raises survival rate
AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company.
Drugs
Health
Pharma
Pfizer’s blood cancer trial data shows survival of more than 2 years
Pfizer Inc.,’s investigational drug for blood cancer, Elrexfio, has shown an overall survival rate of 24.6 months in a single-arm trial, according to.
Drugs
Health
Pharma
Vaccine Alliance steps up bid to end rabies by 2030 after Covid-19 pause
The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and.